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Purpose: To evaluate the results from two software tools for mea-
surement of mammographic breast density and compare 
them with observer-based scores in a large cohort of 
women.
Materials and 
Methods:
Following written informed consent, a data set of 36 281 
mammograms from 8867 women were collected from six 
United Kingdom centers in an ethically approved trial. 
Breast density was assessed by one of 26 readers on a 
visual analog scale and with two automated density tools. 
Mean differences were calculated as the mean of all the 
individual percentage differences between each measure-
ment for each case (woman). Agreement in total breast 
volume, fibroglandular volume, and percentage density 
was assessed with the Bland-Altman method. Association 
with observer’s scores was calculated by using the Pearson 
correlation coefficient (r).
Results: Correlation between the Quantra and Volpara outputs 
for total breast volume was r = 0.97 (P , .001), with a 
mean difference of 43.5 cm3 for all cases representing 
5.0% of the mean total breast volume. Correlation of the 
two measures was lower for fibroglandular volume (r = 
0.86, P , .001). The mean difference was 30.3 cm3 for 
all cases representing 21.2% of the mean fibroglandular 
tissue volume result. Quantra gave the larger value and 
the difference tended to increase with volume. For the 
two measures of percentage volume density, the mean dif-
ference was 1.61 percentage points (r = 0.78, P , .001). 
Comparison of observer’s scores with the area-based den-
sity given by Quantra yielded a low correlation (r = 0.55, 
P , .001). Correlations of observer’s scores with the volu-
metric density results gave r values of 0.60 (P , .001) and 
0.63 (P , .001) for Quantra and Volpara, respectively.
Conclusion: Automated techniques for measuring breast density show 
good correlation, but these are poorly correlated with ob-
server’s scores. However automated techniques do give 
different results that should be considered when inform-
ing patient personalized imaging.
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correctly assess the relative propor-
tions of glandular and fatty tissue while 
accounting for variations in breast 
shape, size, fibroglandular pattern, and 
the various radiographic factors used. 
Density scores are then given either on 
a continuous scale as a percentage (11) 
or within discrete ranges, such as the 
four-point Breast Imaging Reporting 
and Data System, BI-RADS (12), scale 
or the Boyd five-point scale (5). Stud-
ies suggest that training and experience 
are essential in ensuring that the scores 
are accurate and reproducible (12,13).
The introduction of full-field dig-
ital mammography technologies has 
provided an opportunity to implement 
automated breast density measurement 
algorithms, which had been initially 
developed for digitized analog mam-
mograms (11,14). These algorithms 
work by applying thresholds to the 
pixel values within the digital image 
to identify the area of the image that 
contains the breast and to then de-
termine the proportion of that breast 
which contains fibroglandular tissue. 
For example, the pixel values with the 
highest signal (radiation dose detected 
by the pixel) can identify the areas of 
the image where no breast tissue has 
attenuated the primary x-ray beam. 
The areas of lowest signal, on the other 
hand, represent areas where the x-rays 
have passed through a section of tissue 
that is relatively most attenuating (15).
Later developments have led to soft-
ware that estimates the volume of dense 
fibroglandular tissue rather than just the 
area represented on the mammogram. 
By using the image pixel data in com-
bination with information about the ac-
quisition parameters (eg, compression 
paddle height, x-ray tube potential, tar-
get, and filter), more recent algorithms 
are capable of providing estimates of the 
relevant tissue volumes by means of der-
ivation of the tissue composition repre-
sented by each pixel (16–18).
The researchers in one small study 
(19) have compared a range of volu-
metric software tools and found that 
the density measurements were in 
substantial agreement with data from 
breast magnetic resonance (MR) imag-
ing. The aim of this work was to evalu-
ate the results from two software tools 
for the measurement of mammographic 
breast density and compare them with 
observer-based scores in a large cohort 
of women.
Materials and Methods
Support for this study was given by 
two companies—Hologic (Bedford, 
Mass) and Mātakina Technology (Wel-
lington, New Zealand). Both provided 
automated breast density software and 
technical advice. The authors had full 
access to all data in the study and the 
information submitted for publication.
Study Data
Standard two-dimensional digital mam-
mograms (n = 36 281) were obtained 
from the TOMosynthesis with digital 
The estimation and measurement of breast density has been reported in many studies during the past 
2 decades (1–9). This has been partly 
driven by the role of breast density as 
a strong, independent, and modifiable 
risk factor of breast cancer (3–5). Most 
of the work has used mammograms 
for the evaluation of density where the 
appearance of the breast reflects var-
iations in the relative amounts of fat, 
connective tissue, and epithelial tissue 
and their different x-ray attenuation 
characteristics (10). Breast density is 
expressed as a percentage of the mam-
mogram occupied by the fibroglandular 
and stromal tissue (9).
Assessment of breast density is 
traditionally performed by a reader 
on the basis of a visual assessment of 
the standard two-view mammogram. 
Consistency of this measure requires 
an experienced observer to be able to 
Implications for Patient Care
 n Automated breast density mea-
surements are objective and are 
not subject to observer vari-
ability, but different systems do 
not produce identical results.
 n Different software tools and ob-
servers’ scores result in variation 
in the number of women classi-
fied in the greater than 50% den-
sity category.
Advances in Knowledge
 n When two observers score breast 
density for the same woman using 
a visual analog scale, in 70% (449 
of 638) of cases (women), their 
scores agree to within 10% but in 
13% (85 of 638) of cases, there is 
disagreement about whether 
breast density was greater or less 
than 50%.
 n There is good agreement for 
overall breast volume when we 
compare two software tools, with 
Quantra giving a median value of 
953.5 cm3 (range, 73.0–4986.5 
cm3) and Volpara giving a 
median value of 921.4 cm3 
(range, 33.4–5009.3 cm3), but 
there is less agreement for 
median fibroglandular tissue 
volume (Quantra, 93.0 cm3 
[range, 4.0–1024.0 cm3]; and 
Volpara, 71.6 cm3 [range, 6.8–
628.5 cm3]) and median per-
centage breast density (Quantra, 
9.5% [range, 1.4%–56.2%]; and 
Volpara, 7.7% [range, 2.5%–
54.2%]), particularly as density 
increases, with Volpara having 
lower values compared with 
Quantra.
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MammographY, or TOMMY, trial in 
the United Kingdom National Health 
Service Breast Screening Program 
(20) (clinical trial registration ISRCTN 
73467396) by using the full-field digital 
mammography system (Selenia Dimen-
sions; Hologic) installed in six centers 
in the United Kingdom. All the systems 
underwent regular quality control test-
ing to demonstrate ongoing compliance 
with expected system performance 
(21). The trial was approved by the 
Scotland A Research Ethics Committee, 
and participants gave written informed 
consent.
Study Cohort
The study cohort included women aged 
47–73 years who were recalled to an 
assessment clinic following abnormal 
screening mammography results and 
women aged 40–49 years with a fam-
ily history of breast cancer who were 
attending annual screening. The imag-
ing protocol for the trial included ac-
quisition of standard two-view mam-
mograms (cranial caudal [CC] and 
mediolateral oblique [MLO]) of both 
breasts, and these images were used 
for the density assessment. A complete 
set of images for a total of 8867 individ-
ual women were available for analysis.
Reader Assessment
In the study, 26 readers were asked to 
assess breast density on a visual analog 
scale, giving a score ranging from 0% to 
100%. For each subject, a single score 
assigned by a single reader was obtained 
at review of the mammograms, except 
for subjects with a family history of 
breast cancer, in whom two readers as-
signed scores. These readers, who were 
not authors of this article, consisted of 
21 radiologists, two breast physicians, 
and three advanced practitioner ra-
diographers, each with a minimum of 2 
years of experience reading at least 5000 
mammograms per year. The visual ana-
log scale is a 10-cm line on a paper form 
on which readers indicate their density 
score by making an appropriate mark, 
with the left end of the line represent-
ing 0% and the right end representing 
100%. Each center then digitized and 
processed the forms to extract density 
scores for each subject on the basis of 
the position of the reader’s mark (11). 
In four centers, this resulted in a scale 
of scores given to the nearest whole per-
centage; however, one center rounded 
scores to the nearest 5%, and another 
center rounded scores to the nearest 
10%. When the readers were scoring 
the images, they were advised not to al-
ter the window levels of images.
Density Assessment with Software
Two software packages were used to as-
sess the breast density on each mam-
mogram (Quantra version 2.0, Hologic; 
and Volpara version 1.4.2, Mātakina 
Technology) (17,22). The output from 
each program consisted of values for the 
absolute volume of fibroglandular tissue 
and overall breast volume, as well as the 
volumetric breast density on a per-im-
age basis. In addition, with Quantra, an 
area-based score was determined.
To obtain the overall score for each 
examination, the absolute values of to-
tal breast volume and fibroglandular 
tissue volume for each of the four views 
(left and right, CC and MLO) were ex-
amined. For cases (women) in which no 
cancer was assessed as being present, 
the largest total breast volume and the 
largest fibroglandular tissue volume 
for each breast (either from the CC 
or MLO view) were separately deter-
mined, and the average tissue volumes 
of the two breasts were calculated. The 
same logic was applied to the scores de-
termined with the Quantra system for 
area breast density (which should nom-
inally be comparable with the observer 
scores).
For cases in which cancer was con-
firmed with histopathologic examina-
tion, results were used from the contra-
lateral breast. We believe this procedure 
to mirror the behavior of observers. 
Also, the rejection of data from the af-
fected breast reflects methods used in 
cancer cohort studies in which mam-
mographic density is assessed from the 
contralateral mammogram (5,9). If no 
contralateral data were available, results 
from the affected breast were used. Vol-
umetric density was calculated from the 
ratio of the fibroglandular tissue volume 
to the overall breast volume.
Statistical Analysis
Agreement in the measurements of 
absolute tissue volumes and density 
measurements was assessed by using 
the Bland-Altman method. The mean 
difference between each measurement 
was derived by subtracting the relevant 
Volpara value from the Quantra value 
and then calculating the mean value of 
this difference for all cases. The mean 
percentage difference was derived by 
expressing the difference for each case 
as a percentage of the mean of the two 
measurements and then calculating 
the mean percentage for all cases. The 
relationship between the various mea-
surements was assessed by calculat-
ing the Pearson correlation coefficient 
(r). Logarithmic transformation of the 
data was performed where examina-
tion of residual plots indicated that the 
data would behave more linearly and 
variance would be more stable when 
compared with the untransformed 
data. These analyses were further 
performed on the fibroglandular tis-
sue volumes above and below 300 cm3 
(mean volume) to assess the software’s 
performance at greater fibroglandular 
volumes.
For the subset of women with a fam-
ily history of breast cancer, breast den-
sity was assessed by two observers at 
each center. In these cases, agreement 
between the observers’ scores was an-
alyzed by examination of the absolute 
difference between the scores.
Results
A complete set of standard mammo-
graphic images (right MLO, left MLO, 
right CC, left CC) from 8867 individual 
women were available for analysis. How-
ever, the software was unable to pro-
duce scores for every image analyzed. 
Reasons for this inability were not avail-
able for the Quantra algorithm; Volpara 
supplied error messages for each image 
without a score. Reasons for algorithm 
failures were varied and are summarized 
in Table 1. Most of the unexpected er-
rors appeared to be related to the in-
correct use of certain exposure settings 
on the acquisition workstation, leading 
to inconsistent values being used in the 
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DICOM image header. Also, as the data 
set was very large, consisting of 36 281 
images, we were unable to manually ex-
clude cases with additional views (eg, 
magnification or mosaic views).
The logical combination of maximal 
tissue volumes from each view resulted 
in scores being used from the MLO view 
in most of the cases. From the Quantra 
results, where there were 16 957 cases 
of paired CC and MLO scores, the MLO 
view gave the largest total breast volume 
in 13 953 cases and the largest fibro-
glandular tissue volume in 12 347 cases. 
From the Volpara results where there 
were 16 991 cases of paired CC and MLO 
scores, the MLO view gave the largest 
total breast volume in 14 469 cases and 
the largest fibroglandular tissue volume 
in 9200 cases. When we combined 
these volumes from both breasts for 
each woman, there were therefore cases 
where the CC view from one breast was 
averaged with the MLO view from the 
other. For the Quantra results, this av-
eraging occurred in 1471 cases for total 
breast volume and in 2495 cases for fi-
broglandular tissue volume. For the Vol-
para results, this averaging occurred in 
1337 cases for total breast volume and 
in 2544 cases for fibroglandular tissue 
volume.
The summary of results for the 
study cohort is shown in Table 2. An 
overall density score was assigned by 
observers in 8391 cases. Quantra scores 
were available for 8512 women, and 
8532 women had scores calculated from 
Volpara software. Observer scores were 
therefore unavailable for 5.4% (476 of 
8391) of the cohort, and Quantra and 
Volpara scores were not generated for 
4.0% (355 of 8867) and 3.8% (335 of 
8867) of the cohort, respectively.
Figure 1 illustrates the comparison of 
total breast volume, as measured with the 
Quantra and Volpara software, through-
out the study population. The Pearson co-
efficient for correlation between Quantra 
breast volume and Volpara breast volume 
was r = 0.97 (P , .001). The mean dif-
ference between the values calculated for 
each case was 43.5 cm3, and the mean 
percentage difference between the values 
was 5.0%, suggesting good agreement 
between the two systems.
Table 1
Summary of Error Messages from Volpara Given as a Reason for Not Obtaining a 
Density Score in the Analysis of 34 755 Images
Error*
No. of  
Images Comment
Breast implant present: yes 32 On review, not all of these images had implants present;  
however, all were stated as such in the DICOM image  
header, suggesting occasional errors in the use of the  
‘implant present’ mode at the acquisition workstation
Invalid quantitative  
values—not a standard  
mammogram?
9 Images that were in this category were ones with implants  
present but not indicated in the DICOM header and  
spot compression images; a mammogram where  
dense tissue was found largely just behind the nipple  
also appeared in this category
Magnification factor too  
large (. 1.1)
770 These were all magnification images that were not  
removed from the image data set
Filter material invalid/unknown 5 These were specimen images identified as such at  
acquisition; this leads to there being no filter specified  
in the DICOM header
Possible mosaic 292 Many of these were mosaic view where there was only  
partial coverage of the breast; some of the images  
in this category were spot compression views
Possible mag view 3 All of these images turned out to be specimens where  
the specimen view was not selected at acquisition
No background—not a  
standard mammogram?
379 On review, these images were collimated so that the  
breast edge was missing
No energy—all fat found 1 This was an implant image not indicated at acquisition
Recorded breast thickness  
invalid
3 Two of these were specimen images where a breast  
thickness of 0 mm is used in the DICOM header; the  
other image appeared to be a magnification view  
where the x-ray system has not recognized it as such  
(ie, broad focus and grid are indicated with a thickness  
of 317 mm)
Note.—DICOM = Digital Imaging and Communications in Medicine.
* The error messages are as transcribed from the software.
Table 2
Summary of Results for the Total Cohort of Cases
Measurement Observers Quantra Volpara
No. of cases* 8391 8512 8532
Breast volume (cm3) . . . 953.5 (73.0–4986.5) 921.4 (33.4–5009.3)
Fibroglandular tissue volume (cm3) . . . 93.0 (4.0–1024.0) 71.6 (6.8–628.5)
Area breast density (%) 37.0 (0, 100) 14.8 (0–76.5) . . .
Volumetric breast density (%) . . . 9.5 (1.4–56.2) 7.7 (2.5–54.2)
Note.—Unless otherwise indicated, numbers are median values, and numbers in parentheses are the minimum and maximum 
values, respectively, in the ranges.
* Cases = women.
Figures 2 and 3 show the distri-
bution and comparison of the fibro-
glandular tissue volumes within the 
breast reported by the two algorithms. 
The Pearson coefficient for correla-
tion between the natural logarithm 
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of Quantra fibroglandular volume and 
the natural logarithm of Volpara fibro-
glandular volume was r = 0.86 (P , 
.001). The mean difference between 
the values calculated for each case was 
30.3 cm3, and the mean percentage 
Figure 1
Figure 1: Bland-Altman plot of total breast volume reported by Volpara 
subtracted from that reported by Quantra compared with the mean of the two 
results. Middle dashed line = mean difference and top and bottom dashed lines 
= 95% limits of agreement (6 2 standard deviations).
difference between the values was 
21.2%, with Quantra giving the larger 
of the two values. The differences be-
tween the two measurements increase 
as the amount of fibroglandular tissue 
increases. This is particularly notice-
able for data above 300 cm3, where 
the mean difference between cases 
is 226.4 cm3 and the correlation co-
efficient reduces to 0.15 (P = .06) if 
only those data are considered. The 
remaining data below 300 cm3 have a 
mean difference between cases of 26.4 
cm3 and a correlation coefficient of 
0.85 (P , .001). In addition, the range 
of results for fibroglandular volume is 
greater for the Quantra system, with 
most values lying between 0 and 400 
cm3, as opposed to results with Vol-
para, with values lying between 0 and 
300 cm3.
Figures 4 and 5 show the results for 
volumetric breast density. The Pearson 
coefficient for correlation between the 
natural logarithm of Quantra volumet-
ric density and the natural logarithm 
of Volpara volumetric density was r = 
0.78 (P , .001). The mean difference 
between the values calculated for each 
case was 1.61 percentage points, and 
the mean percentage difference be-
tween the values was 16.3%.
Figures 6 and 7 show the results 
for breast density estimated from the 
projected mammogram, the area-based 
breast density score assigned by the 
observers, and the Quantra software. 
The Volpara software did not give an 
area-based density result. The Pearson 
coefficient for correlation between the 
natural logarithm of the observer den-
sity scores and the natural logarithm of 
the Quantra area-based density was r = 
0.55 (P , .001).
Figure 8 shows a comparison of 
the area-based breast density assigned 
a score by the observers and the volu-
metric density measurement from each 
program. The Pearson coefficient for 
correlation between the observer den-
sity scores and the natural logarithms 
of the volumetric densities was r = 0.60 
(P , .001) for Quantra and r = 0.63 
(P , .001) for Volpara, although there 
does appear to be a better correla-
tion in breasts with lower density. The 
Figure 2
Figure 2: Histogram shows distribution of fibroglandular tissue volume across the 
study population, as measured by Quantra (blue) and Volpara (yellow). There were 
30 cases in the Quantra data set and one case in the Volpara data set that had 
volumes greater than 600 cm3, and these data are not shown on the histogram.
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of the way that the visual analog scale 
was processed in two centers, with one 
rounding results to within the nearest 
large numbers of values given at each 
5% mark on the observer histogram 
in Figures 7 and 8 are a consequence 
Figure 4
Figure 4: Histogram shows distribution of volumetric breast density across 
the study population, as measured by Quantra (blue) and Volpara (yellow). There 
was one case from each data set that had a volumetric density greater than 50%.
Figure 3
Figure 3: Bland-Altman plot of fibroglandular tissue volume reported by Vol-
para subtracted from that reported by Quantra compared with the mean of the 
two results. Middle dashed line = mean difference and top and bottom dashed 
lines = 95% limits of agreement (6 2 standard deviations).
5% and the other rounding results to 
the nearest 10%. Figure 9 shows how 
the Quantra outputs of area-based and 
volumetric density compare.
For the cases in women with a 
family history of breast cancer, density 
was assessed by two observers at each 
of the centers, giving us 638 cases with 
two scores for comparison. In 70% 
(449 of 638) of these cases, the score 
agreed to within 10%; however, in 8% 
of cases, the score disagreed by more 
than 20%. The 54 cases with more 
than 20% disagreement were found 
across the whole range of densities, 
with 33 of them in the density range 
of 50%–75%. In 13% (85 of 638) of 
cases, one reader assigned a score to 
the density above 50%, with the other 
reader assigning a score to the density 
below 50%.
Discussion
The two automated density assess-
ment techniques have relatively good 
agreement in the evaluation of the 
overall breast volume; there was less 
agreement in the assessment of the 
fibroglandular volumes. We presume 
from the agreement in total volume 
that there are similarities in the way 
each algorithm identifies the breast 
against the background, while each 
applies their own corrections to ac-
count for compression paddle height 
and tilt and to estimate the volume at 
the edge of the breast where the pad-
dle is not in contact with the breast 
(17,19,23).
Although there was relatively good 
agreement at lower fibroglandular vol-
umes, it became poorer as those vol-
umes increased, particularly above 300 
cm3. The reasons for this discrepancy 
are most likely due to the differing 
ratios of fibroglandular, adipose, and 
skin tissues allocated to each pixel, on 
the basis of their relative x-ray atten-
uation with reference to pixels in the 
image defined as pure adipose or fatty 
tissue (19,22). As density increases, it 
becomes harder to identify these ref-
erence areas, and each manufactur-
er’s solution to this problem is likely 
to result in differences in the final 
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While the specific corrections that 
each algorithm makes to account for 
paddle tilt are unknown because of their 
proprietary nature, Kallenberg et al 
(26) have shown that such corrections 
volumetric density results (17). Fur-
ther differences might be the way that 
skin and fibroglandular tissue are dif-
ferentiated in the assessment of dense 
tissue (18,24,25).
Figure 5
Figure 5: Bland-Altman plot of volumetric breast density reported by Volpara 
subtracted from that reported by Quantra compared with the mean of the two 
results. Middle dashed line = mean difference and top and bottom dashed lines 
= 95% limits of agreement (6 2 standard deviations).
significantly influence fibroglandular tis-
sue volumes and volumetric densities. In 
larger fatty breasts, the paddle tilt gen-
erates an inhomogeneity in the mam-
mogram, which can cause dense tissue 
volumes to be overestimated, especially 
when intentionally flexible paddles are 
used (23). Conversely, in dense breasts, 
the increased height at the chest wall 
edge of the mammogram can lead to an 
underestimation of density (26).
There is low correlation between 
observer scores of breast density and 
automated analysis scores. Observer 
measurement of breast density has 
been shown in other studies to be 
affected by interobserver variability 
(12,25,27,28). When the histograms 
of the area-based measurements from 
both human observers and software 
analysis are examined, there is clearly 
a difference in the distribution of 
scores. This may in part be caused by 
the observers’ application of a semi-
volumetric approach to the assess-
ment rather than a purely area-based 
Figure 6
Figure 6: Histograms show distribution of area-based breast density across the study population from the observers (left) and the Quantra software (right).
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One possible technical reason for 
the difference between observer-based 
density scores and automated scores 
could be the processing of the displayed 
image. The software analyzes the raw 
digital data, whereas the observers 
make their estimation of density on pro-
cessed images optimized for display at 
the workstation and have the ability to 
alter the window width and level of the 
gray scale applied to the image’s pixels. 
This adjustment can substantially alter 
the image presentation. In this study, 
readers were advised not to alter the 
window levels.
In the current study, it is not possible 
to know what the ground truth is with 
regard to breast density measurement. 
Both of the automated density measure-
ment tools used in this study have been 
shown to correlate with measurements 
made with MR imaging (17,19,24), with 
methods using a calibration phantom 
(21) and with visual assessment using 
Breast Imaging Reporting and Data 
System categories (17,30). Correlation, 
however, does not necessarily mean 
agreement between methods.
In recent work, Wang et al (19) ret-
rospectively analyzed the breast density 
methods (25,29), it is the software 
that produces the more comparable 
results.
one. However, when we compared 
the distribution with those found in 
the literature for visual and threshold 
Figure 8
Figure 8: Scatter plots compare the observer area-based breast density scores with the volumetric measurements from Quantra (left) and Volpara (right).
Figure 7
Figure 7: Scatter plot compares the observer and Quantra scores for the 
area-based breast density.
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of 99 women and compared the per-
formance of Quantra and Volpara with 
that of a fuzzy-clustering segmentation 
method on MR images. Total breast vol-
ume with both mammographic measure-
ment tools was highly correlated with 
MR imaging results (r = 0.95), although 
these researchers reported a greater 
difference between Quantra and Volpara 
than we have found. One possible expla-
nation may be their use of the CC image 
and our use of the higher score from ei-
ther the MLO or the CC view. This is 
also likely to have an effect on the volu-
metric density measurements that were 
reported to be a median of 22.0% and 
13.3% for Quantra and Volpara, respec-
tively, which are larger than those found 
in our work. For fibroglandular volume, 
the difference between the reported me-
dian values was 36.2 cm3, with Quantra 
giving the larger score, which is similar 
to that found in our study.
One of the limitations of this study 
was that, despite the same cases being 
submitted to each of the three density 
measurement methods, the failure in 
some cases to provide a score means 
that the population used for comparing 
each of the three methods is different. 
Density is not routinely assessed in the 
National Health Service Breast Screen-
ing Programme, and so, it was some-
times overlooked during image reading. 
However, because each comparison of 
any two methods uses the results where 
the populations coincide, and are there-
fore identical, the effect of this differ-
ence is likely to be small. Also, the vi-
sual analog scale data were rounded to 
5% in some cases and 10% in others, 
which presents another limitation of the 
study, although, again, the effect of this 
difference is unlikely to be large. Finally, 
to obtain percentage density scores and 
absolute volumes, we combined the den-
sity scores from each image given by 
the two software tools using the same 
logic for both. In their derivation of a 
category-based score for the subject, the 
software tools may combine the results 
using a different method than that used 
in the current study. The fact that the 
women selected for this study are from 
two different groups, those with abnor-
mal mammographic results and those 
with a family history of breast cancer, is 
not thought to be a confounding factor.
Breast density has been correlated 
with risk of developing breast cancer 
(3–5,14,31). Because cancers originate 
in the fibroglandular tissue, it is pro-
posed that measurements that describe 
its volume would be a better predictor of 
risk than those based on projected area 
(1,6,31). If volumetric density is to be 
used to estimate breast cancer risk, it 
is important that the measurements are 
reliable. Technical differences in the way 
in which each software package deter-
mines the fibroglandular tissue volume, 
and therefore the density, produce dif-
ferent values. This factor needs to be 
considered when density is used to in-
form patient personalized imaging.
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